Progestrade (CLONE) Review

When a broker reaches our editorial desk with no independent user reviews, no verifiable regulatory footprint and a domain that appears to be a clone of a legitimate operation, we treat it as a red flag until proven otherwise. Our process for Progestrade (CLONE) began with a cross-check of the official domain, http://www.progestrade.com/, against public regulatory registers and corporate records. We also searched for any independent trader feedback, industry database entries, or social-media presence that could corroborate the broker's claims.

What we found was a striking absence of verifiable information. The country of registration is unknown, the founding date is unknown, and there are no licences on file with any regulator we could identify. The FXCanary Scam Risk Score of 55/100 (Elevated) reflects two specific risk flags: no verified regulatory license on file, and no verifiable website or social-media presence. In this review, we will walk through what these findings mean for a trader considering Progestrade, and why the lack of transparency is itself a warning sign.

Our records for Progestrade (CLONE) contain no company registration number, no registered address, and no corporate entity name beyond the trading name. This is unusual even for offshore brokers, which typically disclose at least a jurisdiction of incorporation. The absence of such basic corporate data means there is no legal entity a trader could pursue in the event of a dispute, and no way to verify the company's legitimacy through official registries.

We attempted to match the web search results against these known facts, but the results returned references to entities with similar names that did not align with the official domain or the absence of licensing. As a result, we have set our confidence in those web results to 'low' and have relied solely on the known facts. In FXCanary's assessment, a broker that cannot or will not provide basic corporate identification is a significant risk factor, as it suggests an intention to operate outside the reach of regulators and legal recourse.

The most critical finding in our review is that Progestrade (CLONE) holds no regulatory licences on file. Our records list zero licences, and we have not been able to verify any registration with a financial authority. This means the broker is not subject to the oversight of any recognised regulator, and traders have no protection under any investor compensation scheme.

To put this in context, consider what a licence from a major regulator would provide. For example, a broker regulated by the UK's Financial Conduct Authority (FCA) must meet strict capital requirements, segregate client funds from its own operational funds, and participate in the Financial Services Compensation Scheme (FSCS), which protects eligible deposits up to £85,000. Similarly, a CySEC-regulated broker in Cyprus must comply with the EU's MiFID II framework, including client money segregation and access to the Investor Compensation Fund. Even offshore regulators, such as those in the Seychelles or the British Virgin Islands, impose some degree of oversight, albeit weaker.

None of these protections apply to Progestrade (CLONE). Without a licence, there is no independent body monitoring its financial health, no requirement to segregate client funds, and no compensation scheme to reimburse traders if the broker collapses or disappears. In our view, this is the single most important factor in assessing the risk of trading with this entity.

Our records do not contain specific details on the account types offered by Progestrade (CLONE), nor do we have verified figures for minimum deposits, spreads, or commissions. The broker's own website may present a range of account tiers, but we have not been able to verify these claims independently. In the absence of confirmed data, we can only assess what the lack of transparency implies.

Typically, brokers offer tiers such as Standard, Gold, and VIP, with higher tiers requiring larger minimum deposits and offering tighter spreads or additional perks. However, for an unregulated broker, these tiers are often used as a marketing tool to encourage larger deposits, which increases the potential loss if the broker is fraudulent. Without verified information, we cannot confirm the actual terms, and we caution traders against depositing funds based on unverified claims.

We advise traders to treat any minimum deposit figure with suspicion until it is confirmed through independent sources. If the broker does not disclose such details clearly, or if the information is inconsistent, it is a further sign of a lack of professionalism.

We were unable to verify which trading platforms Progestrade (CLONE) offers. The broker's website may claim to provide MetaTrader 4 or MetaTrader 5, which are industry-standard platforms, but we have no independent confirmation. In our experience, legitimate brokers typically offer well-known platforms with a track record of reliability, and they provide clear information about how to download and use them.

For an unregulated broker, the choice of platform is less important than the underlying integrity of the operation. Even if a broker offers MetaTrader, it can still manipulate trade execution or refuse withdrawals. The platform itself does not provide protection against broker misconduct. Without verified platform information, we cannot assess the quality of the trading experience, and we consider this another gap in the broker's transparency.

Our records do not specify the range of tradable instruments available at Progestrade (CLONE). The broker may claim to offer forex, commodities, indices, or cryptocurrencies, but we have not been able to verify these claims. In the absence of confirmed data, we cannot comment on the breadth or depth of the product offering.

For traders, the availability of instruments is a practical consideration, but it is secondary to the safety of funds. Even if a broker offers a wide range of assets, it is meaningless if the broker is not regulated and cannot be trusted to honour trades. We would advise traders to focus on the regulatory status first and foremost, and only then consider the product range.

One of the most telling aspects of any broker is its deposit and withdrawal process. For Progestrade (CLONE), we have no verified information on payment methods, processing times, or fees. This is a major concern because withdrawal issues are among the most common complaints against unregulated brokers.

Legitimate brokers typically offer a range of deposit methods, including bank transfers, credit cards, and e-wallets, and they process withdrawals within a reasonable timeframe. They also clearly disclose any fees. An unregulated broker may impose hidden fees, delay withdrawals, or refuse to process them altogether. Without verified information, we cannot rule out these risks.

We strongly advise traders to test the withdrawal process with a small amount before depositing significant funds. If the broker delays or complicates the withdrawal, it is a clear warning sign.

Given the lack of regulation and transparency, we cannot recommend Progestrade (CLONE) for any category of trader. Beginners, who are most vulnerable to scams, should avoid it entirely. Experienced traders who understand the risks of unregulated brokers might consider it only for speculative purposes, but even then, the absence of verified information makes it difficult to assess the true risk.

Scalpers and high-frequency traders, who rely on tight spreads and fast execution, would find it impossible to verify whether the broker offers competitive conditions. Swing traders and long-term investors, who may hold positions for days or weeks, face the risk that the broker could disappear with their funds at any time. In short, no trader profile is a good fit for an unregulated, low-transparency broker.

In FXCanary's assessment, Progestrade (CLONE) presents an elevated risk of financial loss. The FXCanary Scam Risk Score of 55/100 reflects the absence of any verified regulatory licence and the lack of a verifiable website or social-media presence. These are not minor concerns; they are fundamental indicators that the broker may be operating outside the bounds of legitimate financial services.

The name 'CLONE' in our records suggests that this entity may be impersonating a legitimate broker. Clone firms are a known tactic in the forex industry, where fraudsters create websites that mimic established brands to lure unsuspecting traders. If Progestrade is indeed a clone, the risk of fraud is even higher, as the operators have no intention of operating a genuine brokerage.

We urge traders to exercise extreme caution. Before depositing any funds, verify the broker's identity through official channels, check for any warnings from financial regulators, and consider using a regulated broker instead. The absence of information is itself a warning, and in this case, it is a loud one.

Our review of Progestrade (CLONE) has found a broker with no verifiable regulatory oversight, no confirmed corporate registration, and no independent user feedback. The lack of transparency is a significant red flag, and we cannot recommend trading with this entity under any circumstances.

For traders who are considering Progestrade, we offer the following practical advice: first, verify the broker's regulatory status through official regulator websites; second, search for any warnings or alerts issued by financial authorities; third, test the withdrawal process with a minimal deposit; and fourth, never invest more than you can afford to lose. Above all, consider using a fully regulated broker that offers client fund segregation and compensation scheme protection.

In the world of forex trading, the absence of regulation is not a minor detail—it is a fundamental risk. Progestrade (CLONE) fails this basic test, and we advise traders to look elsewhere for their brokerage needs.